As a result, the present study aims to investigate the association between BB-DNA and cognitive decline in patients with mild cognitive impairment (MCI) and AD during a two-year follow-up, as well as the influence of BB-DNA on peripheral inflammatory response and plasma BDNF levels, which may provide information on the neuronal neurotrophin [22]. The gene discussed is BDNF; the disease is Alzheimer disease.